Hi Lopez, you know my views with regards stem cell therapies...

Hi Lopez, you know my views with regards stem cell therapies from my previous postings. In this specific case (Pediatric GVHD), I believe that the data from the trials, the quantitative analysis of of the potency- survival rate relationship (product quality/strength that the company has addressed) and the results of a multitude of studies (in vivo and in vitro) conducted around the world leaves me with little doubt that Remestemcel-L has demonstrated that it is the only ethical and moral treatment available at the moment. When you consider the history and results from Ruxolitinib, Remestemcel-L is a far better alternative with demonstrated superior benefits, specially in those with the most severe cases. Fingers crossed